New Zealand markets open in 2 hours 10 minutes

Amylyx Pharmaceuticals, Inc. (AMLX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7750-0.0550 (-3.01%)
As of 03:50PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-184,015
49,271
-198,375
-87,931
-42,280
-
Depreciation & amortisation
327
1,088
487
52
1
-
Stock-based compensation
16,714
37,161
21,714
3,136
243
-
Change in working capital
8,654
-65,661
-1,641
4,595
2,599
-
Accounts receivable
-2,797
-24,744
-15,306
0
-
-
Inventory
-69,079
-73,129
-9,769
0
-
-
Accounts payable
4,040
15,882
1,854
670
1,418
-
Other working capital
-160,510
10,678
-182,397
-75,152
-36,848
-
Other non-cash items
-
-
-
5,228
1,738
356
Net cash provided by operating activities
-158,418
11,919
-179,871
-74,799
-36,697
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,092
-1,241
-2,526
-353
-151
-
Purchases of investments
-154,313
-300,826
-415,873
-49,053
0
-
Sales/maturities of investments
148,411
394,120
179,411
3,000
0
-
Net cash used for investing activities
-7,994
92,053
-238,988
-46,406
-151
-
Cash flows from financing activities
Debt repayment
-
0
0
-263
-
-
Common stock issued
-
0
432,447
0
-
-
Other financing activities
-2,674
-3,451
-2,847
-2,733
-
-
Net cash used provided by (used for) financing activities
198,562
3,543
431,789
158,506
46,823
-
Net change in cash
31,587
107,675
12,865
37,314
9,975
-
Cash at beginning of period
76,866
63,245
50,380
13,066
3,091
-
Cash at end of period
109,016
170,920
63,245
50,380
13,066
-
Free cash flow
Operating cash flow
-158,418
11,919
-179,871
-74,799
-36,697
-
Capital expenditure
-2,092
-1,241
-2,526
-353
-151
-
Free cash flow
-160,510
10,678
-182,397
-75,152
-36,848
-